Bisacodyl/magnesium citrate/senna/sucrose

Gamma-Secretase Inhibitor XXIII, Abeta42-Selective (g-secret

Gedatolisib (PF-05212384, PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ and mTOR with IC50 of 0.4 nM, 5.4 nM and 1.6 nM in cell-free assays, respectively.A PI3K and FRAP inhibitor.

Gedatolisib (PF-05212384, PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ and mTOR with IC50 of 0.4 nM, 5.4 nM and 1.6 nM in cell-free assays, respectively.A PI3K and FRAP inhibitor.

Gedatolisib (PF-05212384, PKI-587) is a highly potent dual inhibitor of PI3Kα, PI3Kγ and mTOR with IC50 of 0.4 nM, 5.4 nM and 1.6 nM in cell-free assays, respectively.A PI3K and FRAP inhibitor.

Immunogen The epitope recognized by PLA0301 maps to a region between residue 50 and 100 of human BRM/SWI2-related Gene 1 using the numbering given in entry NP_003063.2 (GeneID 6597).

GPR17 is a G protein-coupled receptor that has been identified as a dualistic receptor recognizing signals from two unrelated chemical families: nucleotides and cysteinyl leukotrienes (CysLTs). The deorphanization of GPR17 supports the suggested

GSK-3β inhibitor 3.

GSK-3β inhibitor 3.

InformationGSK1324726A (I-BET726) GSK1324726A (I-BET726) is a highly selective inhibitor of BET family proteins with IC50 of 41 nM, 31 nM, and 22 nM for BRD2, BRD3, and BRD4, respectively.TargetsBRD4 (Cell-free assay): BRD3 (Cell-free assay): BRD2

InformationGSK1324726A (I-BET726) GSK1324726A (I-BET726) is a highly selective inhibitor of BET family proteins with IC50 of 41 nM, 31 nM, and 22 nM for BRD2, BRD3, and BRD4, respectively.TargetsBRD4 (Cell-free assay): BRD3 (Cell-free assay): BRD2

InformationGSK1324726A (I-BET726) GSK1324726A (I-BET726) is a highly selective inhibitor of BET family proteins with IC50 of 41 nM, 31 nM, and 22 nM for BRD2, BRD3, and BRD4, respectively.TargetsBRD4 (Cell-free assay): BRD3 (Cell-free assay): BRD2

InformationGSK1324726A (I-BET726) GSK1324726A (I-BET726) is a highly selective inhibitor of BET family proteins with IC50 of 41 nM, 31 nM, and 22 nM for BRD2, BRD3, and BRD4, respectively.TargetsBRD4 (Cell-free assay): BRD3 (Cell-free assay): BRD2